Santhera Pharmaceuticals Holding AG (SPHDF)
OTCMKTS · Delayed Price · Currency is USD
16.28
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
SPHDF Market Cap
SPHDF has a market cap or net worth of $269 million as of February 12, 2026. Its market cap has increased by 28.12% in one year.
Market Cap
269.00M
Enterprise Value
298.59M
Revenue
61.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
$16.28
Market Cap Chart
Since November 3, 2006, SPHDF's market cap has decreased from 284.68M to 269.00M, a decrease of -5.51%. That is a compound annual growth rate of -0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 269.00M | 26.25% |
| Dec 30, 2025 | 213.07M | 15.51% |
| Dec 30, 2024 | 184.46M | 71.97% |
| Dec 29, 2023 | 107.26M | 31.69% |
| Dec 30, 2022 | 81.45M | 33.38% |
| Dec 30, 2021 | 61.07M | 0.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |